Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1593 of 5804
-
HIV drug shows promise against Hard-to-Treat vulvar cancer
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of nelfinavir when given together with cisplatin and external beam radiation therapy in treating patients with vulvar cancer that has spread to nearby tissue or lymph nodes (locally advanced) and cannot be removed by surge…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for liver cancer return after transplant: drug trial launches
Disease control Recruiting nowThis is a phase 2 study that will assess the investigational drug, cabozantinib, in patients with liver cancer (specifically hepatocellular carcinoma) and who had received a liver transplant as a part of curative care, but the cancer has come back (recurred). The purpose of this …
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New PET tracer could sharpen diagnosis of blood cancers
Diagnosis Recruiting nowChemokine receptor CXCR4 is normally expressed on T-lymphocytes, B-lymphocytes, monocytes, macrophages, neutrophils and eosinophils as well as hematopoietic stem and progenitor cells (HSPC) in the bone marrow. 68Ga-Pentixafor PET/CT represents a promising method for the in vivo a…
Phase: EARLY_PHASE1 • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
New drug cocktail shows promise for relapsed myeloma
Disease control CompletedA Study Evaluating Treatment of Multiple Myeloma with Carfilzomib in Combination with Pomalidomide and Dexamethasone
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 26, 2026 13:41 UTC
-
Breathing in calm: new sedation method may keep ICU patients Clear-Headed
Prevention OngoingThe objective of the study is to determine the impact on the frequency of occurrence of delirium of an early inhaled sedation strategy (from induction in rapid sequence if intubation in intensive care, or from admission if intubated in pre -hospital) by Isoflurane using an ANACON…
Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Experimental combo aims to wipe out stubborn leukemia cells
Disease control OngoingSingle center, open-label, phase 2 study to determine the efficacy of cirmtuzumab consolidation in patients with measurable disease on venetoclax.
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 26, 2026 12:46 UTC
-
Home workouts boost fitness in kids with single ventricle hearts
Symptom relief CompletedSurvival of children with single ventricles ("half a heart") beyond the neonatal period has increased dramatically with the staged Fontan palliation. Yet, long-term morbidity remains high. By the age of 40, 50% of Fontan patients will have died or undergone heart transplantation.…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
NICU antibiotic study questions routine use for tiniest babies
Knowledge-focused CompletedThe goal of the NANO trial is to study the longstanding clinical practice of empirically administering intravenous antibiotics to extremely low birthweight (ELBW) infants in the first days of life. In this 802-subject multicenter placebo-controlled randomized clinical trial, the …
Phase: PHASE4 • Sponsor: Michael Morowitz • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug aims to help kids with rare genetic short stature grow taller
Disease control OngoingShort stature can be caused by a number of genetic etiologies, many of which directly affect the growth plate. The FGFR3/CNP pathway is central to growth of the chondrocyte. The study team hypothesizes that patients with selected genetic causes of short stature that interact with…
Phase: PHASE2 • Sponsor: Andrew Dauber • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Hidden danger: study probes blood clot risk in cancer patients with COVID-19
Knowledge-focused CompletedStudy Rational Since December 2019, outbreak of COVID-19 caused by a novel virus SARS-Cov-2 has spread rapidly around the world and became a pandemic issue. First data report high mortality in severe patients with 30% death rate at 28 days. Exact proportions of the reasons of de…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
MRI-Guided heart procedure aims to stop dangerous rhythms
Disease control CompletedPrevious monocentric experiences have already highlighted the role of preoperative cardiac imaging, in particular of cardiac magnetic resonance (CMR) and tomography (CT), in improving the ablation results of scar-related ventricular tachycardia (VT). A better characterization of …
Phase: PHASE4 • Sponsor: Azienda Ospedaliero, Universitaria Pisana • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a plant compound tame COVID-19's deadly inflammation?
Disease control OngoingThe purpose of this study is to test whether Fisetin, a senolytic drug, can assist in preventing an increase in the disease's progression and alleviate complications of coronavirus due to an excessive inflammatory reaction.
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Camera pill could revolutionize bowel cancer screening
Diagnosis CompletedThe investigatior believe that implementing camera capsule endoscopy as a filter test to colonoscopy will increase screening participation, increase the number of individuals with detected intermediate- high risk adenomas or cancer, reduce the colonoscopy demand and reduce the nu…
Phase: NA • Sponsor: Odense University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
Stem cell treatment shows promise for knee pain relief
Symptom relief CompletedThis study aims to compare the efficacy of Umbilical Cord Mesenchymal Stem Cell and secretome between arthroscopy and without arthroscopy intervention in OA patients. This study has 4 arms namely Arthroscopy + Booster, Arthroscopy + Pre-conditioning, Non-Arthroscopy + Booster, No…
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New drug cocktail aims to shrink lung tumors after standard treatment fails
Disease control Recruiting nowThe purpose of this study is to determine if the combination of the three anti-cancer drugs carboplatin, paclitaxel, and ramucirumab is helpful in shrinking tumors or delaying tumor growth in participants with non-small cell lung cancer. This study will also assess whether it is …
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Blood test spots hidden cancer after surgery in HPV head & neck patients
Diagnosis CompletedThe purpose of this study is to test a new liquid biopsy assay for detecting residual disease after surgery in patients with HPV-associated head and neck cancer.
Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Which ACL graft gets young athletes back in the game faster?
Disease control OngoingIn primary pediatric Anterior cruciate ligament (ACL) reconstruction, the quadriceps tendon with either tendon and patellar bone or an all-tendon graft is commonly employed. However, no randomized control trial has sought to discern the superior graft option in regards to both sh…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Pacemaker's 'Smart Pacing' may zap away heart danger without shocks
Disease control OngoingMedtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted withi…
Sponsor: Medtronic • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could a lower steroid dose plus exercise help boys with duchenne?
Disease control CompletedThe study team will determine the potential of low dose twice weekly prednisone and whether exercise training can synergize to delay disease progression and improve muscle strength/physical function in boys with Duchenne muscular dystrophy (DMD). Current standard of care (daily p…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New hope for young cancer patients: drug shows promise against tough tumors
Disease control CompletedThe main purpose of this study is to evaluate the antitumor activity and safety of lenvatinib (MK-7902/E7080) in children, adolescents, and young adults with relapsed or refractory solid malignancies after administration. Participants were enrolled into Ewing sarcoma (EWS), rhabd…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC